Literature DB >> 33446574

Roles of the BAP1 Tumor Suppressor in Cell Metabolism.

Anna Han1, Timothy J Purwin1, Andrew E Aplin2,3.   

Abstract

BRCA1-associated protein 1 (BAP1) is emerging as an intensively studied cancer-associated gene. Germline mutations in BAP1 lead to a cancer syndrome, and somatic loss is found in several cancer types. BAP1 encodes a deubiquitinase enzyme, which plays key roles in cell-cycle regulation, cell death, and differentiation. Recent studies have demonstrated that BAP1 is also involved in several aspects of cellular metabolism, including metabolic homeostasis, glucose utilization, control of ferroptosis, and stress response. A better knowledge of the metabolic roles of cancer-associated genes is important to understanding tumor initiation and progression, as well as highlighting potential therapeutic avenues. With this review, we summarize the current knowledge regarding BAP1-mediated regulation of metabolic activities that may support new strategies to treat BAP1-mutated cancers. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33446574      PMCID: PMC8178170          DOI: 10.1158/0008-5472.CAN-20-3430

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   13.312


  84 in total

1.  O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway.

Authors:  Christina M Ferrer; Thomas P Lynch; Valerie L Sodi; John N Falcone; Luciana P Schwab; Danielle L Peacock; David J Vocadlo; Tiffany N Seagroves; Mauricio J Reginato
Journal:  Mol Cell       Date:  2014-05-22       Impact factor: 17.970

Review 2.  ROS in Cancer: The Burning Question.

Authors:  Iok In Christine Chio; David A Tuveson
Journal:  Trends Mol Med       Date:  2017-04-17       Impact factor: 11.951

3.  Loss of the tumor suppressor BAP1 causes myeloid transformation.

Authors:  Anwesha Dey; Dhaya Seshasayee; Rajkumar Noubade; Dorothy M French; Jinfeng Liu; Mira S Chaurushiya; Donald S Kirkpatrick; Victoria C Pham; Jennie R Lill; Corey E Bakalarski; Jiansheng Wu; Lilian Phu; Paula Katavolos; Lindsay M LaFave; Omar Abdel-Wahab; Zora Modrusan; Somasekar Seshagiri; Ken Dong; Zhonghua Lin; Mercedesz Balazs; Rowena Suriben; Kim Newton; Sarah Hymowitz; Guillermo Garcia-Manero; Flavius Martin; Ross L Levine; Vishva M Dixit
Journal:  Science       Date:  2012-08-09       Impact factor: 47.728

Review 4.  p53 in survival, death and metabolic health: a lifeguard with a licence to kill.

Authors:  Flore Kruiswijk; Christiaan F Labuschagne; Karen H Vousden
Journal:  Nat Rev Mol Cell Biol       Date:  2015-07       Impact factor: 94.444

Review 5.  Tumour predisposition and cancer syndromes as models to study gene-environment interactions.

Authors:  Michele Carbone; Sarah T Arron; Bruce Beutler; Angela Bononi; Webster Cavenee; James E Cleaver; Carlo M Croce; Alan D'Andrea; William D Foulkes; Giovanni Gaudino; Joanna L Groden; Elizabeth P Henske; Ian D Hickson; Paul M Hwang; Richard D Kolodner; Tak W Mak; David Malkin; Raymond J Monnat; Flavia Novelli; Harvey I Pass; John H Petrini; Laura S Schmidt; Haining Yang
Journal:  Nat Rev Cancer       Date:  2020-05-29       Impact factor: 60.716

6.  Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1.

Authors:  Shahram Misaghi; Søren Ottosen; Anita Izrael-Tomasevic; David Arnott; Mohamed Lamkanfi; James Lee; Jinfeng Liu; Karen O'Rourke; Vishva M Dixit; Angus C Wilson
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

7.  BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.

Authors:  Michele Carbone; Laura Korb Ferris; Francine Baumann; Andrea Napolitano; Christopher A Lum; Erin G Flores; Giovanni Gaudino; Amy Powers; Peter Bryant-Greenwood; Thomas Krausz; Elizabeth Hyjek; Rachael Tate; Joseph Friedberg; Tracey Weigel; Harvey I Pass; Haining Yang
Journal:  J Transl Med       Date:  2012-08-30       Impact factor: 5.531

8.  Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivation.

Authors:  Sushmita Bhattacharya; Pranita Hanpude; Tushar Kanti Maiti
Journal:  Sci Rep       Date:  2015-12-18       Impact factor: 4.379

Review 9.  Beyond the Warburg Effect: How Do Cancer Cells Regulate One-Carbon Metabolism?

Authors:  Adam Rosenzweig; John Blenis; Ana P Gomes
Journal:  Front Cell Dev Biol       Date:  2018-08-15

10.  BAP1 links metabolic regulation of ferroptosis to tumour suppression.

Authors:  Yilei Zhang; Jiejun Shi; Xiaoguang Liu; Li Feng; Zihua Gong; Pranavi Koppula; Kapil Sirohi; Xu Li; Yongkun Wei; Hyemin Lee; Li Zhuang; Gang Chen; Zhen-Dong Xiao; Mien-Chie Hung; Junjie Chen; Peng Huang; Wei Li; Boyi Gan
Journal:  Nat Cell Biol       Date:  2018-09-10       Impact factor: 28.824

View more
  10 in total

1.  Analysis of uveal melanomas and paired constitutional DNA for exclusion of a BAP1-tumor predisposition syndrome.

Authors:  Yasaman Arjmand Abbassi; Claudia Le Guin; Norbert Bornfeld; Nikolaos E Bechrakis; Michael Zeschnigk; Dietmar R Lohmann
Journal:  Fam Cancer       Date:  2022-08-03       Impact factor: 2.446

2.  Pyruvate dehydrogenase inactivation causes glycolytic phenotype in BAP1 mutant uveal melanoma.

Authors:  Anna Han; Vivian Chua; Usman Baqai; Timothy J Purwin; Nelisa Bechtel; Emily Hunter; Manoela Tiago; Erin Seifert; David W Speicher; Zachary T Schug; J William Harbour; Andrew E Aplin
Journal:  Oncogene       Date:  2022-01-20       Impact factor: 8.756

3.  Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies.

Authors:  Yu-Chuan Yan; Guang-Xiao Meng; Zi-Niu Ding; Yan-Feng Liu; Zhi-Qiang Chen; Lun-Jie Yan; Ya-Fei Yang; Hui Liu; Chun-Cheng Yang; Zhao-Ru Dong; Jian-Guo Hong; Tao Li
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

4.  Integrated analysis of anti-tumor roles of BAP1 in osteosarcoma.

Authors:  Dong Hu; Yongbin Zheng; Xuehai Ou; Lijun Zhang; Xiaolong Du; Shaoyan Shi
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738

5.  Case report: Mesothelioma and BAP1 tumor predisposition syndrome: Implications for public health.

Authors:  Luigi Vimercati; Domenica Cavone; Francesco Fortarezza; Maria Celeste Delfino; Romina Ficarella; Angela Gentile; Angela De Palma; Giuseppe Marulli; Luigi De Maria; Concetta Caporusso; Andrea Marzullo; Antonio d'Amati; Daniele Egidio Romano; Antonio Caputi; Stefania Sponselli; Gabriella Serio; Federica Pezzuto
Journal:  Front Oncol       Date:  2022-08-04       Impact factor: 5.738

6.  Molecular Profile and Prognostic Value of BAP1 Mutations in Intrahepatic Cholangiocarcinoma: A Genomic Database Analysis.

Authors:  Alessandro Rizzo; Riccardo Carloni; Angela Dalia Ricci; Alessandro Di Federico; Deniz Can Guven; Suayib Yalcin; Giovanni Brandi
Journal:  J Pers Med       Date:  2022-07-29

7.  Ferroptosis in glioma treatment: Current situation, prospects and drug applications.

Authors:  Yuhang Zhou; Chaoyou Fang; Houshi Xu; Ling Yuan; Yibo Liu; Xiaoyu Wang; Anke Zhang; Anwen Shao; Danyang Zhou
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

8.  MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer.

Authors:  Natsumi Tsuboyama; Aileen Patricia Szczepanski; Zibo Zhao; Lu Wang
Journal:  Genome Biol       Date:  2022-09-30       Impact factor: 17.906

Review 9.  Post-Translational Modifications of Deubiquitinating Enzymes: Expanding the Ubiquitin Code.

Authors:  Yanfeng Wang; Feng Wang
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

Review 10.  Metabolic Alterations and Therapeutic Opportunities in Rare Forms of Melanoma.

Authors:  Anna Han; Zachary T Schug; Andrew E Aplin
Journal:  Trends Cancer       Date:  2021-06-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.